BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30697072)

  • 1. MNX1-AS1 is a functional oncogene that induces EMT and activates the AKT/mTOR pathway and MNX1 in breast cancer.
    Cheng Y; Pan Y; Pan Y; Wang O
    Cancer Manag Res; 2019; 11():803-812. PubMed ID: 30697072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MNX1-AS1 accelerates the epithelial-mesenchymal transition in osteosarcoma cells by activating MNX1 as a functional oncogene.
    Wu F; Zhong Y; Lang XB; Tu YL; Sun SF
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8194-8202. PubMed ID: 31646549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNA MNX1-AS1 Knockdown Inhibits Cell Proliferation and Migration in Ovarian Cancer.
    Lv Y; Li H; Li F; Liu P; Zhao X
    Cancer Biother Radiopharm; 2017 Apr; 32(3):91-99. PubMed ID: 28414551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
    Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
    Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lncRNA MNX1-AS1 Promotes Glioblastoma Progression Through Inhibition of miR-4443.
    Gao Y; Xu Y; Wang J; Yang X; Wen L; Feng J
    Oncol Res; 2019 Feb; 27(3):341-347. PubMed ID: 29678219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA MNX1-AS1 promotes migration and invasion of esophageal squamous cell carcinoma by upregulating IGF2.
    Zheng DN; Zhang CJ; Sun GP
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6179-6185. PubMed ID: 31364117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of lncRNA MNX1-AS1 suppresses cell proliferation, migration, and invasion in prostate cancer.
    Li Z; Wang F; Zhang S
    FEBS Open Bio; 2019 May; 9(5):851-858. PubMed ID: 30980513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of LncRNA MNX1-AS1/PPFIA4 Activates AKT/HIF-1
    Sun Q; Gui Z; Zhao Z; Xu W; Zhu J; Gao C; Zhao W; Hu H
    J Oncol; 2022; 2022():8303409. PubMed ID: 36226248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA MNX1-AS1 overexpression promotes the invasion and metastasis of gastric cancer through repressing CDKN1A.
    Ma JX; Yang YL; He XY; Pan XM; Wang Z; Qian YW
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4756-4762. PubMed ID: 31210302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis.
    Shen Y; Lv M; Fang Y; Lu J; Wu Y
    J Ovarian Res; 2021 Nov; 14(1):161. PubMed ID: 34789303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA MNX1-AS1 functions as a competing endogenous RNA to regulate epithelial-mesenchymal transition by sponging MiR-744-5p in colorectal cancer.
    Huang S; Sun Y
    Biosci Biotechnol Biochem; 2021 Feb; 85(3):568-578. PubMed ID: 33590038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA MNX1-AS1 promotes the progression of cervical cancer through activating MAPK pathway.
    Liu X; Yang Q; Yan J; Zhang X; Zheng M
    J Cell Biochem; 2019 Mar; 120(3):4268-4277. PubMed ID: 30302806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis.
    Chu J; Li H; Xing Y; Jia J; Sheng J; Yang L; Sun K; Qu Y; Zhang Y; Yin H; Wan J; He F
    Biomed Pharmacother; 2019 Aug; 116():109029. PubMed ID: 31170665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and significance of LncRNA MNX1-AS1 in non-small cell lung cancer.
    Liu G; Guo X; Zhang Y; Liu Y; Li D; Tang G; Cui S
    Onco Targets Ther; 2019; 12():3129-3138. PubMed ID: 31118668
    [No Abstract]   [Full Text] [Related]  

  • 15. MYC-Activated LncRNA
    Wu QN; Luo XJ; Liu J; Lu YX; Wang Y; Qi J; Liu ZX; Huang QT; Liu ZK; Lu JB; Jin Y; Pu HY; Hu PS; Zheng JB; Zeng ZL; Ju HQ; Xie D; Zhao Q; Xu R
    Cancer Res; 2021 May; 81(10):2636-2650. PubMed ID: 33782099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA MNX1-AS1 promotes hepatocellular carcinoma proliferation and invasion through targeting miR-218-5p/COMMD8 axis.
    Ji D; Wang Y; Sun B; Yang J; Luo X
    Biochem Biophys Res Commun; 2019 Jun; 513(3):669-674. PubMed ID: 30982576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis.
    Wang J; Xing H; Nikzad AA; Liu B; Zhang Y; Li S; Zhang E; Jia Z
    J Pharmacol Exp Ther; 2020 Mar; 372(3):237-247. PubMed ID: 31843814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Non-Coding RNA MNX1-AS1 Promotes Progression of Triple Negative Breast Cancer by Enhancing Phosphorylation of Stat3.
    Li J; Li Q; Li D; Shen Z; Zhang K; Bi Z; Li Y
    Front Oncol; 2020; 10():1108. PubMed ID: 32754442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA MNX1-AS1 Contributes to Laryngeal Squamous Cell Carcinoma Growth and Migration by Regulating mir-744-5p/bcl9/β-Catenin Axis.
    Ma B; Ren G; Xu J; Yin C; Shi Y
    Cell Transplant; 2021; 30():9636897211005682. PubMed ID: 33821684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.